Novo Holdings Biomarin Pharmaceutical Inc Transaction History
Novo Holdings
- $1.23 Billion
- Q4 2024
A detailed history of Novo Holdings transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Novo Holdings holds 490,000 shares of BMRN stock, worth $34.5 Million. This represents 2.62% of its overall portfolio holdings.
Number of Shares
490,000
Previous 490,000
-0.0%
Holding current value
$34.5 Million
Previous $34.4 Million
6.49%
% of portfolio
2.62%
Previous 2.41%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.6 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.37 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.28 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.04 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$916 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...